- HMRC has paused the imposition of VAT on free post-trial drugs following backlash from pharmaceutical companies.
- Drug firms warned that VAT on free medicines discourages clinical research and early access programs in the UK.
- Bayer suspended new patient enrollments for critical unmet needs due to the VAT issue, with other companies considering similar actions.
- The government is reviewing the policy after industry complaints, aiming to protect the UK’s reputation in life sciences research.
- The pause is intended to safeguard access to unlicensed treatments for patients with severe, untreatable illnesses before full NHS approval.
Source: pharmacy.biz
Note that this post was (partially) written with the help of AI. It is always useful to review the original source material, and where needed to obtain (local) advice from a specialist.
Latest Posts in "United Kingdom"
- HMRC Offers Free Access to Customs Declaration Data for Enhanced Compliance and Governance
- Mandatory HMRC Registration for Tax Advisors from May 2026: Key Requirements and Deadlines
- Tribunal Rules Gift Hamper Basket Not a Separate VAT Supply in Clearwater Hampers v HMRC Case
- Court Rules Education Grant Funding Is VAT-Exempt Business Income; HMRC Issues Updated Guidance
- One Third of UK Small Firms May Quit EU Trade Due to Costs and Complex Rules
